Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

The document discusses how to identify and manage common skin conditions in children.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Low-level laser therapy combined with NB-UVB is a safe and potentially effective treatment for stable vitiligo.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Secukinumab can cause hair loss, which may improve after stopping the medication.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Pranlukast and mirabegron may work as new diabetes drugs.

The baby’s hair loss was due to a rare genetic condition, not treatable by usual methods.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.